Member Info for Toyin

Thanks Aquae.

Is it me or is the narrative changing from sleep/fatigue, to now include things like “epidermis” “stratum corneum” (this is where TEWL takes place) and “smoother skin”

“Clinically, it has been shown to improve mood and sleep quality, reduce signs of skin fatigue, and reinforce the epidermis and stratum corneum. Consumers experience smoother, more radiant skin, a more rested appearance, faster fatigue recovery upon waking, and improved emotional balance.”

Friedman, just wouldn’t want you wasting your time. I would definitely be emailing and asking how exactly will the sampling work.

Hope it goes well for you.

Friedman, SOH is using slight of hand by calling an ingredient a product, they dont even use it in any of their products on the website. I would email them and ask what products is sweetbiotix in at this tasting session.

Researcher, its an rns reach, excitment over nothing.

Sign up to Investegate, you will get everything then.

https://www.investegate.co.uk/announcement/rns/optibiotix-health--opti/sweetbiotix-sampling/9567626

Just for you net.

https://www.youtube.com/watch?v=wYsMjEeEg4g

Mol, now you know who took the extra 1.4m.

Https://www.gcimagazine.com/brands-products/skin-care/news/22966479/prestige-and-mass-beauty-converge-as-premiumization-selective-spending-and-digital-commerce-reshape-growth?utm_source=newsletter-html&utm_medium=email&utm_campaign=GCI+E-Newsletter+05-11-2026

Letitrun, no apologies needed. You are comfortable with your investment and you think SOH is doing a good job, good luck too you.

Re Zenakine, Rome wasn’t built in a day, but at least Sbtx has started.

As for calling you an idiot, I’m still waiting for the evidence, just because you say something doesn’t make it fact.

Regarding the 25% shareholder, time will tell. If you knew his net worth you wouldn’t have made that statement. A little knowledge is dangerous.

All the best.

Letitrun, you seem to be getting about flustered.

Please enlighten me on when I called you an idiot re Axisbiotix.

Royalties on this ingredients tiny amount (3%) same as Matrixyl, that didn’t do too badly did it.

This disciple reported the CEO to AIM, FCA & FRC, because I was smelling a lot of BS. I hope I am part of the reason the CEO got ousted and the company investigated, because what was going on was wrong, end of.

What you also seem to be unaware of is Zenakine launched in Europe & Asia in 2025, so royalties have been paid, unlike opti that hasn’t launched Jack regards to sweet in over ten years!

I never invested in the management, I invested in Skinbiotix (i.e. Zenakine). If you think for one minute a 25% shareholder (who has just bought more during suspension) will let this go for a song, you need your head feeling.

The difference between you and I is, I know Ashman did a very bad job, you still believe SOH is doing a good one. And there lies your frustration.

Enough said!

https://youtu.be/BGz6LsedQAY?si=pPtEMVBEXzCGDY7T&t=308

josh, of course it wasn’t a single misstep, thats plain to see, we didn’t need £4m for the launch, just do the maths, along with the “if we dont launch now we may not be guaranteed shelf space next year” it was all horse shyt. companies and individuals launch on superdrug every week.

he bought duff acquisitions and tried to cover it up, starting with the singers note, then the nda, then the sd launch, then the synergies take time ******, etc, etc. he backed himself into a corner and kept on digging. i have to say, the size and breadth of incompetence (i’m being kind) has surprised me but thats the sign of a good confidence man, i should have reported him a lot sooner. he had me fooled for a long time which i am not proud of.

To be fair, there isn’t a lot they could say as they are awaiting the report, I appreciate they have updated us. Agree Bazza, Hunt has to go.

Whackery, this all kicked of on the on the 13/2, MD was still buying and crossed his last threshold on 27/3. I think that speaks volumes.

Whackery, you email IR and explain your frustrations.

Net, you are better directing your query to the company.

Yes I know, I found both the Scandia cosmetics & VZK labs. The point I am making is investors are wanting to see one of the VIP’s using it, I don’t think it will happen anytime soon.

On the point of VIP’s, they don’t exist and never have done, it was a figment of Ashman’s imagination. 91% of Croda customer launch’s in 2024 were local & regional, that’s where investors need to focus. As an example, I think Medik8 will be one of the first if not the first to launch in U.K. (owned by L’Oréal).

Https://www.gcimagazine.com/brands-products/skin-care/article/22963544/regenerative-skin-care-the-antiaging-killer

Interesting article. Whilst not mentioned directly, Zenakine is in formulations of Luceane & DS-CERAMIX-V.

I think investors looking for Zenakine on packaging are wasting their time, I got pretty much the same response on both ingredients.

Short answer: you generally can’t easily buy finished consumer products that explicitly list Croda’s DS-CERAmix-V™—it’s a B2B cosmetic ingredient used by formulators, and most brands don’t disclose the exact trade name on packaging.

Short answer: you can’t easily buy finished retail products that explicitly list Croda’s “Luceane™”—at least not yet in a transparent, consumer-facing way.

Here’s why, and what you can look for instead:

1. What Luceane actually is

Croda sells Luceane™ as a cosmetic ingredient, not a finished product.

It’s a bio-fermented active (Pseudoalteromonas ferment extract) used for:

anti-ageing

“skin energy” / radiance

pollution defence

So brands buy it and put it into their own formulas (serums, creams, masks).

2. Why you can’t find named products (yet)

There are a few key reasons:

a) Ingredient branding is hidden

Most skincare brands don’t list supplier trade names like “Luceane™” on packaging.

Instead, they list the INCI name:

Pseudoalteromonas Ferment Extract

So even if a product contains Luceane, it won’t say so.

End

Bubs, dont be too hard on yourself. I understand we are responsible for our investment decisions but I caveat that with, if you are lied to, all bets are off and the blame gets shifted. We got conned, it's as simple as that. SBTX is not and never has been a bad company, the IP is fantastic (as Croda is showing) it just had bad management. I never imagined it would be this bad, but you live and you learn.

Bubs, I think everyone is concerned because of the uncertainty but we just have to let it play out.

On your point of “big boys” again this is something that was manifested by Ashman, investors need to forget anything he said and just look at what Croda have said. Page 10 of the annual report, 91% of product launches in 2024 was by Local & Regional, up from 81% in 2014, this big boy takes is a red herring.

Current market environment.

"The current environment in consumer markets is marked by three things which are driving our priorities and actions in Consumer Care. They are a return of

demand for innovation, greater demand from outside Europe and the continued rise in importance of local and regional (L&R) customers."

Https://www.linkedin.com/pulse/how-cosmetics-industry-embracing-mind-body-wellness-7qxmc